[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@avidresearch Avatar @avidresearch avidresearch

avidresearch posts on X about $abvx, $wve, weight loss, delta the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks finance cryptocurrencies

Social topic influence $abvx, $wve, weight loss, delta, $lly, $nvo, rates, $gmab, $38b, $3b

Top assets mentioned Eli Lilly and Company (LLY) Novo-Nordisk (NVO) SuperRare (RARE) Alnylam Pharmaceuticals, Inc. (ALNY) BridgeBio Pharma, Inc. Common Stock (BBIO)

Top Social Posts #

Top posts by engagements in the last XX hours

"@A_May_MD Also begs question if $abvx should get some credit for chrons disease as well given compelling efficacy"
@avidresearch Avatar @avidresearch on X 2025-07-22 20:21:54 UTC 10.7K followers, 1263 engagements

"$WVE if INHBE weight loss at month X is just XX% of GLPs but has NO notable GI side effects (big if) is it still valuable as both mono-therapy and weight loss maintenance post GLP1 $LLY $NVO"
@avidresearch Avatar @avidresearch on X 2025-07-17 15:24:00 UTC 10.7K followers, 9430 engagements

"@JacobPlieth @ApexOnco Really sad to see how much time and energy was wasted on TIGIT"
@avidresearch Avatar @avidresearch on X 2025-07-24 11:35:53 UTC 10.7K followers, XXX engagements

"$ABVX went through @A_May_MD summary and as usual found it to be very compelling. Is market able to appreciate delta for clinical remission is for Week X (vs 12) while comparing topline results. Well established that remission rates increase over time"
@avidresearch Avatar @avidresearch on X 2025-07-22 12:44:14 UTC 10.7K followers, 3636 engagements

"@PikaCapital $gmab 2029 darzalex patent cliff"
@avidresearch Avatar @avidresearch on X 2025-07-16 12:51:17 UTC 10.7K followers, XXX engagements

"Maybe $RARE gets aquired if OI hits. $2.5-$3B /year sales with current pipeline and Angelman readout gives further upside. All that while trading at $3.8B valuation"
@avidresearch Avatar @avidresearch on X 2025-07-09 17:31:04 UTC 10.7K followers, 3348 engagements

"@mikeconvente @A_May_MD SKYRIZI was at week XX 😀 so $ABVX achieves results faster and safer"
@avidresearch Avatar @avidresearch on X 2025-07-22 21:21:25 UTC 10.7K followers, XXX engagements

"@A_May_MD The serious infection risk = placebo. Oral and clean safety = first line dominance"
@avidresearch Avatar @avidresearch on X 2025-07-22 20:21:05 UTC 10.7K followers, 1011 engagements

"$WVE typically does earnings call in first week of Aug. July 30th is a bit early. We may see AATD updated multi-dose data with this ER"
@avidresearch Avatar @avidresearch on X 2025-07-24 11:40:56 UTC 10.7K followers, 7173 engagements

"This reminds me a bit of $BBIO month XX time point for overall survival while $ALNY used up to XX months"
@avidresearch Avatar @avidresearch on X 2025-07-22 12:45:30 UTC 10.7K followers, 1006 engagements

"Endoscopic improvement delta almost Rinvoq like but with cleaner safety. Cc @A_May_MD"
@avidresearch Avatar @avidresearch on X 2025-07-22 20:12:25 UTC 10.7K followers, 3296 engagements

"@houndcl @jfais20 Yes INHBE has X commercialization pathways 1) mono 2) Post GLP1 weight maintenance 3) combo with low dose GLP1 $WVE"
@avidresearch Avatar @avidresearch on X 2025-07-17 17:22:41 UTC 10.7K followers, XXX engagements

"@DGTrading101 Bracing for a no-open today"
@avidresearch Avatar @avidresearch on X 2025-07-22 22:23:16 UTC 10.7K followers, XXX engagements

"Guys $abvx showed these impressive results at week X as @A_May_MD repeatedly pointed out vs recent ph2 trials that were using wk12 (or longer). Makes results that much more impressive"
@avidresearch Avatar @avidresearch on X 2025-07-22 20:46:28 UTC 10.7K followers, 5788 engagements

"@mikeconvente @A_May_MD Makes me think $abvx drug can sell $10B if chrons comes thru as well. Another benign AE drug except its oral"
@avidresearch Avatar @avidresearch on X 2025-07-22 21:27:24 UTC 10.7K followers, XXX engagements

"@jfais20 $WVE INHBE will always have to a slower rate of weight loss than GLP1 (preclinical data 👇showing slower rate for INHBE) they can meet or exceed GLP-1 real world weight loss However they can outpace GLP1 weight loss estimand in real world by vastly higher compliance rate"
@avidresearch Avatar @avidresearch on X 2025-07-17 17:04:23 UTC 10.7K followers, 1009 engagements